---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-240282"
form_type: "8-K"
ticker: "CRSP"
cik: "0001674416"
company_name: "CRISPR Therapeutics AG"
filed_at: "2025-10-15T23:59:59+00:00"
generated_at: "2026-05-17T03:45:01.043522+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CRISPR Therapeutics files $600M ATM offering through Jefferies

## Summary
- Filed prospectus supplement to sell up to $600M of common shares at-the-market.
- Offering uses existing shelf registration (Form S-3ASR filed Aug 5, 2024).
- Jefferies LLC acts as sole sales agent; shares sold at company's discretion.
- Legal opinion of Walder Wyss AG filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0001193125-25-240282
- form_type: 8-K
- ticker: CRSP
- cik: 0001674416
- company_name: CRISPR Therapeutics AG
- filed_at: 2025-10-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674416/000119312525240282/0001193125-25-240282-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674416/000119312525240282/crsp-20251015.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-240282
- JSON: https://secwatch.observer/filing/0001193125-25-240282.json
- Plain text: https://secwatch.observer/filing/0001193125-25-240282.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.